Tag Archives: Rheumatology

Arzerra ofatumumab and Rituxan rituximab Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese Arzerra (ofatumumab) and Rituxan (rituximab): Drug Safety Communication – New Boxed Warning, Recommendations to Decrease Risk of Hepatitis B Reactivation AUDIENCE: Oncology, Pharmacy, Rheumatology, Patient ISSUE: FDA approved changes … Continue reading

Share
Posted in FDA 2013, FDA Safety Communication, Oncology, Patients, Pharmacy, Rheumatology | Tagged , , , , , , , , , , , , , , | Comments Off

Tumor Necrosis Factor-alpha (TNFα) Blockers Label Change

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseTumor Necrosis Factor-alpha (TNFα) Blockers: Label Change – Boxed Warning Updated for Risk of Infection from Legionella and Listeria including Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), and … Continue reading

Share
Posted in FDA 2011, FDA Label Change, Gastroenterology, Oncology, Rheumatology | Tagged , , , , , , , | Comments Off